Phase 4 COPD and Suboptimal Inspiratory Flow Rate

PHASE4CompletedINTERVENTIONAL
Enrollment

404

Participants

Timeline

Start Date

January 7, 2022

Primary Completion Date

November 13, 2023

Study Completion Date

November 20, 2023

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Revefenacin

Revefenacin 175 mcg administered once daily for 84 days via nebulization

DRUG

Tiotropium

Tiotropium 18 mcg administered once daily for 84 days via Spiriva HandiHaler®

DRUG

Revefenacin Placebo

Placebo for Revefenacin administered once daily for 84 days via nebulization

DRUG

Tiotropium Placebo

Placebo for Tiotropium administered once daily for 84 days via Spiriva HandiHaler®

Trial Locations (76)

10708

Theravance Biopharma Investigational Site, Bronxville

12308

Theravance Biopharma Investigational Site, Schenectady

20745

Theravance Biopharma Investigational Site, Oxon Hill

21046

Theravance Biopharma Investigational Site, Columbia

21286

Theravance Biopharma Investigational Site, Towson

21401

Theravance Biopharma Investigational Site, Annapolis

24210

Theravance Biopharma Investigational Site, Abingdon

27103

Theravance Biopharma Investigational Site, Winston-Salem

27284

Theravance Biopharma Investigational Site, Kernersville

27607

Theravance Biopharma Investigational Site, Raleigh

28078

Theravance Biopharma Investigational Site, Huntersville

28112

Theravance Biopharma Investigational Site, Monroe

28207

Theravance Biopharma Investigational Site, Charlotte

28601

Theravance Biopharma Investigational Site, Hickory

29072

Theravance Biopharma Investigational Site, Lexington

29204

Theravance Biopharma Investigational Site, Columbia

29303

Theravance Biopharma Investigational Site #2, Spartanburg

Theravance Biopharma Investigational Site, Spartanburg

29340

Theravance Biopharma Investigational Site, Gaffney

29379

Theravance Biopharma Investigational Site, Union

29406

Theravance Biopharma Investigational Site, North Charleston

29615

Theravance Biopharma Investigational Site, Greenville

29621

Theravance Biopharma Investigational Site, Anderson

29732

Theravance Biopharma Investigational Site, Rock Hill

32117

Theravance Biopharma Investigational Site, Daytona Beach

32174

Theravance Biopharma Investigational Site, Ormond Beach

32789

Theravance Biopharma Investigational Site, Winter Park

32825

Theravance Biopharma Investigational Site, Orlando

33155

Theravance Biopharma Investigational Site, Miami

33186

Theravance Biopharma Investigational Site, Miami

33511

Theravance Biopharma Investigational Site, Brandon

33606

Theravance Biopharma Investigational Site, Tampa

33756

Theravance Biopharma Investigational Site, Clearwater

33765

Theravance Biopharma Investigational Site site 2, Clearwater

Theravance Biopharma Investigational Site, Clearwater

34239

Theravance Biopharma Investigational Site, Sarasota

34748

Theravance Biopharma Investigational Site, Leesburg

35501

Theravance Biopharma Investigational Site, Jasper

37067

Theravance Biopharma Investigational Site, Franklin

37601

Theravance Biopharma Investigational Site, Johnson City

37909

Theravance Biopharma Investigational Site, Knoxville

43215

Theravance Biopharma Investigational Site, Columbus

43235

Theravance Biopharma Investigational Site, Columbus

43302

Theravance Biopharma Investigational Site, Marion

45236

Theravance Biopharma Investigational Site, Cincinnati

45242

Theravance Biopharma Investigational Site, Cincinnati

46324

Theravance Biopharma Investigational Site, Hammond

46383

Theravance Biopharma Investigational Site, Valparaiso

48336

Theravance Biopharma Investigational Site, Farmington Hills

53110

Theravance Biopharma Investigational Site, Cudahy

59808

Theravance Biopharma Investigational Site, Missoula

60305

Theravance Biopharma Investigational Site, River Forest

60415

Theravance Biopharma Investigational Site, Chicago Ridge

63141

Theravance Biopharma Investigational Site, St Louis

63301

Theravance Biopharma Investigational Site, Saint Charles

75092

Theravance Biopharma Investigational Site, Sherman

77598

Theravance Biopharma Investigational Site, Webster

78028

Theravance Biopharma Investigational Site, Kerrville

78229

Theravance Biopharma Investigational Site, San Antonio

78503

Theravance Biopharma Investigational Site, McAllen

80228

Theravance Biopharma Investigational Site, Lakewood

84067

Theravance Biopharma Investigational Site, Roy

84120

Theravance Biopharma Investigational Site, West Valley City

85018

Theravance Biopharma Investigational Site, Phoenix

85715

Theravance Biopharma Investigational Site, Tucson

87108

Theravance Biopharma Investigational Site, Albuquerque

89106

Theravance Biopharma Investigational Site, Las Vegas

91786

Theravance Biopharma Investigational Site, Upland

92120

Theravance Biopharma Investigational Site, San Diego

92663

Theravance Biopharma Investigational Site, Newport Beach

95207

Theravance Biopharma Investigational Site, Stockton

97202

Theravance Biopharma Investigational Site, Portland

97504

Theravance Biopharma Investigational Site, Medford

97527

Theravance Biopharma Investigational Site, Grants Pass

99204

Theravance Biopharma Investigational Site, Spokane

02747

Theravance Biopharma Investigational Site, North Dartmouth

Sponsors
All Listed Sponsors
collaborator

Viatris Inc.

INDUSTRY

lead

Theravance Biopharma

INDUSTRY

NCT05165485 - Phase 4 COPD and Suboptimal Inspiratory Flow Rate | Biotech Hunter | Biotech Hunter